Trinity Biotech (TRIB) Change in Cash (2021 - 2024)

Trinity Biotech has disclosed Change in Cash across 4 years of filings, most recently posting $2.4 million for Q4 2024.

• Change in Cash for Q4 2024 came in at $2.4 million, up 200.29% year-over-year; the trailing twelve-month figure through Dec 2024 was -$8.7 million (up 38.52% YoY), and the FY2025 annual result was -$100000.0, down 105.88% from the prior year.
• Change in Cash came in at $2.4 million for Q4 2024 at Trinity Biotech, up from -$2.4 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $2.4 million in Q4 2024 to a low of -$8.0 million in Q3 2023.
• The 4-year median for Change in Cash is -$2.1 million (2021), against an average of -$2.2 million.
• Across the five-year window, Change in Cash sank 240.68% in 2023 and soared 200.29% in 2024, its largest moves.
• Trinity Biotech's Change in Cash stood at -$1.7 million in 2021, then jumped by 59.12% to -$708000.0 in 2022, then tumbled by 240.68% to -$2.4 million in 2023, then jumped by 200.29% to $2.4 million in 2024.
• The last three Change in Cash figures came in at $2.4 million (Q4 2024), -$2.4 million (Q4 2023), and -$8.0 million (Q3 2023), per Business Quant data.